Page last updated: 2024-10-24

cefixime and Asymptomatic Colonization

cefixime has been researched along with Asymptomatic Colonization in 1 studies

Cefixime: A third-generation cephalosporin antibiotic that is stable to hydrolysis by beta-lactamases.
cefixime : A third-generation cephalosporin antibiotic bearing vinyl and (2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(carboxymethoxy)imino]acetamido groups at positions 3 and 7, respectively, of the cephem skeleton. It is used in the treatment of gonorrhoea, tonsilitis, pharyngitis, bronchitis, and urinary tract infections.

Research Excerpts

ExcerptRelevanceReference
"Cefixime was recommended as a single-dose treatment for gonorrhoea from 2005 to 2010, during which time resistance increased, and subsequently declined."1.46Estimating the fitness cost and benefit of cefixime resistance in Neisseria gonorrhoeae to inform prescription policy: A modelling study. ( Didelot, X; White, PJ; Whittles, LK, 2017)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Whittles, LK1
White, PJ1
Didelot, X1

Other Studies

1 other study available for cefixime and Asymptomatic Colonization

ArticleYear
Estimating the fitness cost and benefit of cefixime resistance in Neisseria gonorrhoeae to inform prescription policy: A modelling study.
    PLoS medicine, 2017, Volume: 14, Issue:10

    Topics: Anti-Bacterial Agents; Asymptomatic Infections; Bisexuality; Cefixime; Cephalosporin Resistance; Cos

2017